Medium- and long-term follow-up of transcatheter closure of ruptured sinus of Valsalva aneurysm in Central Europe population

Abstract

Sinus of Valsalva aneurysm (SVA) is an uncommon and mostly congenital cardiac anomaly which predominantly affects Asian males [1]. Congenital SVA is caused by deficiency of normal elastic tissue between aortic media and the annulus fibrosus (abnormal bulbus cordis development) [2]. Ventricular septal defect (VSD), aortic regurgitation (AR), and bicuspid aortic valve (BAV) are frequent concomitant lesions in this SVA type. Acquired SVA can result from previous cardiac surgery, endocarditis, syphilis, atherosclerosis, or chest injury [3]. SVA arises from the right sinus of Valsalva in 80-85% cases, from the non-coronary sinus in 5-15%, and rarely from the left sinus. Despite being generally asymptomatic, SVA can compress adjacent structures, resulting in acute

Case Report: Right Heart Failure Mistaken for Obesity—A Fault of Telemedicine

“…However, an increasing number of transcatheter closures are being described ( 6 ). Despite favorable outcomes of surgical repair, transcatheter closure remains a good alternative for patients with a small ruptured area and no concomitant heart defects requiring surgery ( 11 , 12 ). The prevalence of ruptured SVA is low compared to other heart defects that can be percutaneously repaired, thus, there are no commercially available devices dedicated to SVA repair.…”

“…The device used in the case presented above was primarily designed to repair a patent ductus arteriosus. Other types of device have also been successfully used ( 6 , 12 , 13 ).…”

A Short Case Report on Ruptured Sinus of Valsalva Aneurysm

“…The operative mortality rate is 1.9%-3.6% with 90% survival at 15 years [3]. The accurate mortality associated with percutaneous closure of ruptured SVA could not be determined due to paucity of large-scale data, but multiple studies have shown good outcomes in select patients [10][11][12][13]. The choice of percutaneous vs surgical intervention depends on multiple factors, including patient's age, comorbidities, hemodynamic status at presentation, coexisting congenital heart defects like ventricular septal defects, aortic regurgitation, underlying obstructive coronary artery disease, size of ruptured SVA, and location in addition to the local cardiac surgeon and interventional cardiologist's expertise.…”

The use of Amplatzer devices in the percutaneous treatment of congenital heart defects in children and adults based on own experience

“…Our experiences in percutaneous closure of ruptured sinuses of Valsalva aneurysm (RSVA) with various devices like ADOI and ASO were described in several papers reflecting various stages of our growing experience and longer patient observation. The last paper (published together with colleagues from the Amosov In stitute in Kyiv, Ukraine) summarized results of RSVA closure in 23 patients, which is one of the largest reported cohorts [15]. We concluded that percutaneous closure of RSVA is (1) safe and effective, however, recanalizations are possible (in a different location); (2) it is also suitable for a second percutaneous attempt.…”